Article

Persistent steatosis retards fibrosis regression during anti-HBV treatment in patients with chronic HBV infection

2023-03-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Despite the increasing prevalence of steatosis in patients with chronic hepatitis B (CHB), whether the changes in steatosis impact fibrosis regression during antiviral therapy remain unclear. We aimed to identify the association between histological changes of steatosis and fibrosis in patients undergone antiviral treatment. <bold>Methods: </bold>Patients with p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a52f31a7-3aa4-551b-9a43-39053c725914
DOI: 10.21203/rs.3.rs-2674262/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Persistent steatosis retards fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionDOI 10.21203/rs.3.rs-2674262/v1Read

Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosisSemantic proximity Read

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsSemantic proximity Read

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLFSemantic proximity Read

Intrahepatic Macrophage Reprogramming Associated with Lipid Metabolism in Hepatitis B Virus-Related Acute-on-Chronic Liver FailureSemantic proximity Read

Virus-related liver cirrhosis: molecular basis and therapeutic options.Semantic proximity Read

A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathwaysSemantic proximity Read

Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.Semantic proximity Read

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertensionSemantic proximity Read

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants.Semantic proximity Read

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertensionSemantic proximity Read

Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease.Semantic proximity Read

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read